![Blaine McKee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Blaine McKee
Director/Miembro de la Junta en VBI VACCINES INC. .
Fortuna: - $ al 31/05/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Athena Kartsaklis | F | 59 | 7 años | |
Nell Beattie | F | 36 | 9 años | |
Steven Gillis | M | 71 |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | 19 años |
Jeff Baxter | M | 62 | 8 años | |
Vaughn Himes | M | 63 | 1 años | |
Joanne Cordeiro | F | 66 | 5 años | |
Michel de Wilde | M | 74 | 8 años | |
Eric S. Lander | M | 67 |
Massachusetts Institute of Technology
| 34 años |
James Shmerling | M | 69 | 6 años | |
Misha Nossov | M | - | 14 años | |
Jason Jing Chen | M | 62 | 6 años | |
Mark Goldberg | M | 69 |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 años |
Anat Naschitz | F | 56 |
OrbiMed Israel Partners LP
![]() OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | 14 años |
Nicole Anderson | F | - | 7 años | |
Damian Braga | M | 68 | 4 años | |
Mathias Schmidt | M | 56 |
ArmaGen, Inc.
![]() ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | 8 años |
Ari Nowacek | M | - |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | - |
Hong Yu | M | 52 | 6 años | |
Peter G. Linde | M | 57 |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | 2 años |
John Dillman | M | 56 | 2 años | |
William Fodor | M | 65 | 7 años | |
Emmanuel Lacroix | M | - |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | - |
Kathleen Fanning | F | - |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | - |
Erez Chimovits | M | 60 |
OrbiMed Israel Partners LP
![]() OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | - |
David Anderson | M | 54 | 8 años | |
Avi Mazaltov | M | 62 | 7 años | |
T. Buckley | M | 48 | 23 años | |
Francisco Diaz-Mitoma | M | 69 | 8 años | |
Nissim Darvish | M | 59 |
OrbiMed Israel Partners LP
![]() OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | 14 años |
John B. Vander Sande | M | 79 |
Massachusetts Institute of Technology
| 32 años |
Curt Dewan | M | - |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | 3 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Daniel Junius | M | 71 | 13 años | |
David Green | M | 59 | 4 años | |
Linda Bain | F | 53 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 años |
David B. Johnston | M | 68 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 años |
John F. Kennedy | M | 75 | 6 años | |
Michael A. Klug | M | - |
Massachusetts Institute of Technology
| 12 años |
Christopher McNulty | M | 47 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 7 años |
Jeffrey Poulton | M | 56 | 14 años | |
Earl Collier | M | 76 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 17 años |
Scott Applebaum | M | 57 | 2 años | |
James Bowling | M | 56 | 10 años | |
Bryan R. Smith | M | - |
Massachusetts Institute of Technology
| - |
Neil Renninger | M | 49 |
Massachusetts Institute of Technology
| 5 años |
Steven Burke | M | 63 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Roger W. Louis | M | 69 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 años |
William R. Mordan | M | 54 | 4 años | |
Scott A. Miller | M | - |
Massachusetts Institute of Technology
| 5 años |
Reza Abhari | M | 62 |
Massachusetts Institute of Technology
| 3 años |
Eric Oliver | M | - |
Massachusetts Institute of Technology
| 7 años |
Wei Zhang | M | 52 | 3 años | |
Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
David Altarac | M | 63 | - | |
Thomas Johannes W. Dittrich | M | 60 | 1 años | |
Saverio la Francesca | M | 62 | 3 años | |
Richard Gregory | M | 66 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 años |
Gloria Matthews | M | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 años |
Sarah Kiely | F | - | 7 años | |
Michael Halpin | M | 62 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 años |
Ian Karp | M | - | 5 años | |
Julie Feder | F | 54 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
James Callaway | M | 68 |
ArmaGen, Inc.
![]() ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | 4 años |
Ludovic Robin | M | - | 8 años | |
Errol Arkilic | M | - |
Massachusetts Institute of Technology
| 6 años |
Christoph Brackmann | M | - | - | |
Brian Schiller | M | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 años |
Mark Enyedy | M | 60 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 años |
Henry Chung | M | - |
Massachusetts Institute of Technology
| 5 años |
Mohsin Ansari | M | - |
Massachusetts Institute of Technology
| 5 años |
Peter Wirth | M | 73 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 años |
David G. Foster | M | - | 3 años | |
S. Mathew | F | 68 | 4 años | |
Joseph J. Villafranca | M | 79 | 14 años | |
Michael Wyzga | M | 69 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 años |
Thilo Semmelbauer | M | 58 |
Massachusetts Institute of Technology
| 2 años |
Steven J. Burakoff | M | 81 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Ian Clark | M | 62 | 2 años | |
Thomas H. Robinson | M | 65 | 6 años | |
Christopher J. Neil | M | 58 |
Massachusetts Institute of Technology
| 6 años |
Gail Fosler | F | 76 | 3 años | |
Albert P. L. Stroucken | M | 76 | 3 años | |
Richard F. Syron | M | 80 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Alan Smith | M | 78 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 años |
Henry E. Blair | M | 80 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 años |
Albert Wong | M | 61 |
Massachusetts Institute of Technology
| 3 años |
David Stout | M | 70 | 6 años | |
Philippe Laffont | M | - |
Massachusetts Institute of Technology
| 6 años |
Cornelius McGillicuddy | M | 83 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
David John Kappler | M | 76 | 12 años | |
Joe Schirripa | M | - |
Massachusetts Institute of Technology
| 6 años |
Ben Shih | M | - |
Massachusetts Institute of Technology
| 4 años |
Gregory Lambrecht | M | - |
Massachusetts Institute of Technology
| 6 años |
Mihnea Moldoveanu | M | - |
Massachusetts Institute of Technology
| 5 años |
John J. Canepa | M | 68 | 5 años | |
Evren Ünver | M | - |
Massachusetts Institute of Technology
| 5 años |
Scott Requadt | M | 56 | 3 años | |
Peter T. Traynor | M | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Andrew C. Singer | M | - |
Massachusetts Institute of Technology
| 5 años |
Sun Kim | M | 52 | 2 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 83 | 83.84% |
Irlanda | 17 | 17.17% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Blaine McKee
- Red Personal